NGM Annual CFO
-$132.20 M
+$12.24 M+8.47%
31 December 2023
Summary:
As of February 5, 2025, NGM annual cash flow from operations is -$132.20 million, with the most recent change of +$12.24 million (+8.47%) on December 31, 2023. During the last 3 years, it has fallen by -$48.71 million (-58.33%).NGM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Quarterly CFO
-$22.96 M
+$4.20 M+15.47%
31 December 2023
Summary:
As of February 5, 2025, NGM quarterly cash flow from operations is -$22.96 million, with the most recent change of +$4.20 million (+15.47%) on December 31, 2023. Over the past year, it has increased by +$18.86 million (+45.10%).NGM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM TTM CFO
-$132.20 M
+$7.44 M+5.33%
31 December 2023
Summary:
As of February 5, 2025, NGM TTM cash flow from operations is -$132.20 million, with the most recent change of +$7.44 million (+5.33%) on December 31, 2023. Over the past year, it has increased by +$18.33 million (+12.17%).NGM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.5% | +45.1% | +12.2% |
| 3 y3 years | -58.3% | -14.6% | -58.3% |
| 5 y5 years | -1640.2% | -427.7% | -221.1% |
NGM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | <-9999.0% | -427.7% | +2860.9% |
NGM Biopharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$132.20 M(-8.5%) | -$22.96 M(-15.5%) | -$132.20 M(-5.3%) |
| Sept 2023 | - | -$27.16 M(-32.5%) | -$139.64 M(-0.7%) |
| June 2023 | - | -$40.25 M(-3.8%) | -$140.63 M(-6.6%) |
| Mar 2023 | - | -$41.83 M(+37.6%) | -$150.53 M(+4.2%) |
| Dec 2022 | -$144.44 M(+97.2%) | -$30.40 M(+8.0%) | -$144.44 M(+9.1%) |
| Sept 2022 | - | -$28.15 M(-43.9%) | -$132.37 M(+16.5%) |
| June 2022 | - | -$50.15 M(+40.3%) | -$113.58 M(+30.9%) |
| Mar 2022 | - | -$35.74 M(+94.9%) | -$86.74 M(+18.5%) |
| Dec 2021 | -$73.23 M(-12.3%) | -$18.34 M(+95.9%) | -$73.23 M(-2.3%) |
| Sept 2021 | - | -$9.36 M(-59.8%) | -$74.93 M(-17.4%) |
| June 2021 | - | -$23.31 M(+4.9%) | -$90.74 M(+4.8%) |
| Mar 2021 | - | -$22.23 M(+10.9%) | -$86.61 M(+3.7%) |
| Dec 2020 | -$83.50 M | -$20.04 M(-20.4%) | -$83.50 M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$25.16 M(+31.2%) | -$78.06 M(+31.0%) |
| June 2020 | - | -$19.18 M(+0.4%) | -$59.59 M(+23.7%) |
| Mar 2020 | - | -$19.11 M(+30.9%) | -$48.18 M(+17.0%) |
| Dec 2019 | -$41.17 M(+442.0%) | -$14.60 M(+118.1%) | -$41.17 M(+110.4%) |
| Sept 2019 | - | -$6.70 M(-13.9%) | -$19.57 M(+4.5%) |
| June 2019 | - | -$7.78 M(-35.7%) | -$18.72 M(+22.9%) |
| Mar 2019 | - | -$12.10 M(-272.7%) | -$15.23 M(+100.5%) |
| Dec 2018 | -$7.60 M(-56.4%) | $7.01 M(-219.8%) | -$7.60 M(-48.0%) |
| Sept 2018 | - | -$5.85 M(+36.4%) | -$14.61 M(+66.8%) |
| June 2018 | - | -$4.29 M(-3.9%) | -$8.75 M(+96.1%) |
| Mar 2018 | - | -$4.46 M | -$4.46 M |
| Dec 2017 | -$17.41 M(-1472.2%) | - | - |
| Dec 2016 | $1.27 M | - | - |
FAQ
- What is NGM Biopharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual CFO year-on-year change?
- What is NGM Biopharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly CFO year-on-year change?
- What is NGM Biopharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals TTM CFO year-on-year change?
What is NGM Biopharmaceuticals annual cash flow from operations?
The current annual CFO of NGM is -$132.20 M
What is the all time high annual CFO for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual cash flow from operations is $1.27 M
What is NGM Biopharmaceuticals annual CFO year-on-year change?
Over the past year, NGM annual cash flow from operations has changed by +$12.24 M (+8.47%)
What is NGM Biopharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of NGM is -$22.96 M
What is the all time high quarterly CFO for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly cash flow from operations is $7.01 M
What is NGM Biopharmaceuticals quarterly CFO year-on-year change?
Over the past year, NGM quarterly cash flow from operations has changed by +$18.86 M (+45.10%)
What is NGM Biopharmaceuticals TTM cash flow from operations?
The current TTM CFO of NGM is -$132.20 M
What is the all time high TTM CFO for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high TTM cash flow from operations is -$4.46 M
What is NGM Biopharmaceuticals TTM CFO year-on-year change?
Over the past year, NGM TTM cash flow from operations has changed by +$18.33 M (+12.17%)